BioCentury
ARTICLE | Company News

Genoptix, Novartis deal

January 31, 2011 8:00 AM UTC

Novartis will acquire Genoptix for $25 per share in cash, or about $470 million. The price is a 27% premium to Genoptix's close of $19.76 on Jan. 21, before the deal was announced. Genoptix, which wil...